Kunming, China

Yifen Wang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Kunming Beiao Technology Company Limited. Active years: 2020.


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yifen Wang: Innovator in Respiratory Disease Treatment

Introduction

Yifen Wang is a prominent inventor based in Kunming, China. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory diseases. Her innovative work has led to the development of a unique pharmaceutical composition that showcases her expertise and dedication to improving health outcomes.

Latest Patents

Yifen Wang holds 1 patent for her invention titled "Pharmaceutical composition for treating respiratory disease." This invention provides a pharmaceutical composition that includes one or more components selected from picrinine, vallesamine, scholaricine, and 19-epischolaricine. The composition is designed to offer a protective effect on the respiratory system and can be utilized in the treatment of relevant diseases.

Career Highlights

Throughout her career, Yifen Wang has worked with notable organizations, including Kunming Beiao Technology Company Limited and the Chinese Academy of Sciences. Her experience in these institutions has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Yifen Wang has collaborated with esteemed colleagues, including Xiaodong Luo and Jianhua Shang. These partnerships have further enhanced her research and development efforts, leading to innovative solutions in respiratory health.

Conclusion

Yifen Wang's contributions to the field of pharmaceuticals, particularly in respiratory disease treatment, highlight her role as a leading inventor. Her dedication to innovation continues to pave the way for advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…